Found: 480
Select item for more details and to access through your institution.
Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET.
- Published in:
- Brain Communications, 2024, v. 6, n. 4, p. 1, doi. 10.1093/braincomms/fcae162
- By:
- Publication type:
- Article
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5143, doi. 10.1002/alz.13859
- By:
- Publication type:
- Article
α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cerebral perfusion in the predementia stages of Alzheimer's disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 9, p. N.PAG, doi. 10.3390/cells11091551
- By:
- Publication type:
- Article
Correction: Boiten et al. Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF. Cells 2021, 10 , 38.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 1, p. 38, doi. 10.3390/cells10010038
- By:
- Publication type:
- Article
Gut Microbiota Composition Is Related to AD Pathology.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2021.794519
- By:
- Publication type:
- Article
Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 10, p. 1229, doi. 10.1177/13524585231188625
- By:
- Publication type:
- Article
Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1070, doi. 10.1177/13524585231176732
- By:
- Publication type:
- Article
Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 14, p. 2231, doi. 10.1177/13524585221118676
- By:
- Publication type:
- Article
Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1121, doi. 10.1177/13524585211028833
- By:
- Publication type:
- Article
Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 102, doi. 10.1177/13524585211010097
- By:
- Publication type:
- Article
CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41122-y
- By:
- Publication type:
- Article
Multicenter Analytical Validation of Aβ40 Immunoassays.
- Published in:
- Frontiers in Neurology, 2017, p. 1, doi. 10.3389/fneur.2017.00310
- By:
- Publication type:
- Article
The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials.
- Published in:
- Frontiers in Aging Neuroscience, 2024, p. 1, doi. 10.3389/fnagi.2024.1382593
- By:
- Publication type:
- Article
Clusters of co-abundant proteins in the brain cortex associated with fronto-temporal lobar degeneration.
- Published in:
- Alzheimer's Research & Therapy, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13195-023-01200-1
- By:
- Publication type:
- Article
A longitudinal study on quality of life along the spectrum of Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01075-8
- By:
- Publication type:
- Article
Rationale and design of the "NEurodegeneration: Traumatic brain injury as Origin of the Neuropathology (NEwTON)" study: a prospective cohort study of individuals at risk for chronic traumatic encephalopathy.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01059-8
- By:
- Publication type:
- Article
Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01053-0
- By:
- Publication type:
- Article
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01051-2
- By:
- Publication type:
- Article
YKL-40 changes are not detected in post-mortem brain of patients with Alzheimer's disease and frontotemporal lobar degeneration.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01039-y
- By:
- Publication type:
- Article
P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01038-z
- By:
- Publication type:
- Article
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00939-9
- By:
- Publication type:
- Article
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00939-9
- By:
- Publication type:
- Article
Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00873-w
- By:
- Publication type:
- Article
Associations of AD Biomarkers and Cognitive Performance with Nutritional Status: The NUDAD Project.
- Published in:
- Nutrients, 2019, v. 11, n. 5, p. 1, doi. 10.3390/nu11051161
- By:
- Publication type:
- Article
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status.
- Published in:
- Journal of Neuroinflammation, 2013, v. 10, n. 1, p. 1, doi. 10.1186/1742-2094-10-35
- By:
- Publication type:
- Article
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Classically and alternatively activated bone marrow derived macrophages differ in cytoskeletal functions and migration towards specific CNS cell types.
- Published in:
- Journal of Neuroinflammation, 2011, v. 8, n. 1, p. 58, doi. 10.1186/1742-2094-8-58
- By:
- Publication type:
- Article
Konsensusprotokoll zur Standardisierung von Entnahme und Biobanking des Liquor cerebrospinalis<sup>1</sup> / A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking.
- Published in:
- Journal of Laboratory Medicine / Laboratoriums Medizin, 2010, v. 34, n. 1, p. 1, doi. 10.1515/JLM.2010.001
- By:
- Publication type:
- Article
High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients.
- Published in:
- Journal of NeuroVirology, 2020, v. 26, n. 4, p. 572, doi. 10.1007/s13365-020-00860-1
- By:
- Publication type:
- Article
Neurofilaments as biomarkers in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 5, p. 552, doi. 10.1177/1352458512443092
- By:
- Publication type:
- Article
The central biobank and virtual biobank of BIOMARKAPD: a resource for studies on neurodegenerative diseases.
- Published in:
- Frontiers in Neurology, 2015, v. 6, p. 1, doi. 10.3389/fneur.2015.00216
- By:
- Publication type:
- Article
Facilitating the validation of novel protein biomarkers for dementia: an optimal workflow for the development of sandwich immunoassays.
- Published in:
- Frontiers in Neurology, 2015, p. 1, doi. 10.3389/fneur.2015.00202
- By:
- Publication type:
- Article
A practical guide to immunoassay method validation.
- Published in:
- Frontiers in Neurology, 2015, p. 1, doi. 10.3389/fneur.2015.00179
- By:
- Publication type:
- Article
Facilitating the validation of novel protein biomarkers for dementia: an optimal workflow for the development of sandwich immunoassays.
- Published in:
- Frontiers in Neurology, 2015, p. 1, doi. 10.3389/fneur.2015.00202
- By:
- Publication type:
- Article
Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0299-x
- By:
- Publication type:
- Article
Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0266-6
- By:
- Publication type:
- Article
Unbiased estimates of cerebrospinal fluid β-amyloid 1-42 cutoffs in a large memory clinic population.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-016-0233-7
- By:
- Publication type:
- Article
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-015-0142-1
- By:
- Publication type:
- Article
The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2014, v. 6, n. 3, p. 1, doi. 10.1186/alzrt257
- By:
- Publication type:
- Article
Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2024, v. 62, n. 7, p. 1252, doi. 10.1515/cclm-2023-1311
- By:
- Publication type:
- Article
Pre-analytical stability of serum biomarkers for neurological disease: neurofilament-light, glial fibrillary acidic protein and contactin-1.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2022, v. 60, n. 6, p. 842, doi. 10.1515/cclm-2022-0007
- By:
- Publication type:
- Article
Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: A systematic review and meta-analysis of exercise intervention trials.
- Published in:
- PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0264557
- By:
- Publication type:
- Article
No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients.
- Published in:
- Frontiers in Molecular Neuroscience, 2018, p. 1, doi. 10.3389/fnmol.2018.00371
- By:
- Publication type:
- Article
Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes.
- Published in:
- Brain: A Journal of Neurology, 2024, v. 147, n. 3, p. 936, doi. 10.1093/brain/awad330
- By:
- Publication type:
- Article
CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 11, p. 4495, doi. 10.1093/brain/awad213
- By:
- Publication type:
- Article
Predicting progression to Alzheimer's disease with human hippocampal progenitors exposed to serum.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 5, p. 2045, doi. 10.1093/brain/awac472
- By:
- Publication type:
- Article
Biomarker A+T−: is this Alzheimer's disease or not? A combined CSF and pathology study.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 3, p. 1166, doi. 10.1093/brain/awac158
- By:
- Publication type:
- Article